Literature DB >> 16831907

Cellular and molecular mechanisms of synovial joint and articular cartilage formation.

Maurizio Pacifici1, Eiki Koyama, Yoshihiro Shibukawa, Changshan Wu, Yoshihiro Tamamura, Motomi Enomoto-Iwamoto, Masahiro Iwamoto.   

Abstract

Synovial joints and articular cartilage play crucial roles in the skeletal function, but relatively little is actually known about their embryonic development. Here we first focused on the interzone, a thin mesenchymal cell layer forming at future joint sites that is widely thought to be critical for joint and articular cartilage development. To determine interzone cell origin and fate, we microinjected the vital fluorescent dye DiI at several peri-joint sites in chick limbs and monitored the behavior and fate of labeled cells over time. Peri-joint mesenchymal cells located immediately adjacent to incipient joints migrated, became part of the interzone, and were eventually found in epiphyseal articular layer and joint capsule. Interzone cells isolated and reared in vitro expressed typical phenotypic markers, including GDF-5, Wnt-14, and CD-44, and differentiated into chondrocytes over time. To determine the molecular mechanisms of articular chondrocyte formation, we carried out additional studies on the ets transcription factor family member ERG and its alternatively spliced variant C-1-1 that we previously found to be expressed in developing avian articular chondrocytes. We cloned the human counterpart of avian C-1-1 (ERGp55Delta81) and conditionally expressed it in transgenic mice under cartilage-specific Col2 gene promotor-enhancer control. The entire transgenic mouse limb chondrocyte population exhibited an immature articular-like phenotype and a virtual lack of growth plate formation and chondrocyte maturation compared to wild-type littermate. Together, our studies reveal that peri-joint mesenchymal cells take part in interzone and articular layer formation, interzone cells can differentiate into chondrocytes, and acquisition of a permanent articular chondrocyte phenotype is aided and perhaps dictated by ets transcription factor ERG.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831907      PMCID: PMC2697570          DOI: 10.1196/annals.1346.010

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  30 in total

1.  Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1.

Authors:  S H Yang; E Vickers; A Brehm; T Kouzarides; A D Sharrocks
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Identification of amino acid residues in the ETS transcription factor Erg that mediate Erg-Jun/Fos-DNA ternary complex formation.

Authors:  A Verger; E Buisine; S Carrère; R Wintjens; A Flourens; J Coll; D Stéhelin; M Duterque-Coquillaud
Journal:  J Biol Chem       Date:  2001-02-23       Impact factor: 5.157

3.  Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton.

Authors:  C Hartmann; C J Tabin
Journal:  Cell       Date:  2001-02-09       Impact factor: 41.582

Review 4.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

5.  Studies on the role of Cux1 in regulation of the onset of joint formation in the developing limb.

Authors:  Gail Lizarraga; Alexander Lichtler; William B Upholt; Robert A Kosher
Journal:  Dev Biol       Date:  2002-03-01       Impact factor: 3.582

Review 6.  When Ets transcription factors meet their partners.

Authors:  Alexis Verger; Martine Duterque-Coquillaud
Journal:  Bioessays       Date:  2002-04       Impact factor: 4.345

7.  The role of ERG (ets related gene) in cartilage development.

Authors:  M Iwamoto; Y Higuchi; M Enomoto-Iwamoto; K Kurisu; E Koyama; H Yeh; J Rosenbloom; M Pacifici
Journal:  Osteoarthritis Cartilage       Date:  2001       Impact factor: 6.576

8.  Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes.

Authors:  D Pfander; B Swoboda; T Kirsch
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

9.  Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300.

Authors:  S Papoutsopoulou; R Janknecht
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

10.  Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes.

Authors:  C Ueta; M Iwamoto; N Kanatani; C Yoshida; Y Liu; M Enomoto-Iwamoto; T Ohmori; H Enomoto; K Nakata; K Takada; K Kurisu; T Komori
Journal:  J Cell Biol       Date:  2001-04-02       Impact factor: 10.539

View more
  59 in total

1.  Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis.

Authors:  Erik R Sampson; Matthew J Hilton; Ye Tian; Di Chen; Edward M Schwarz; Robert A Mooney; Susan V Bukata; Regis J O'Keefe; Hani Awad; J Edward Puzas; Randy N Rosier; Michael J Zuscik
Journal:  Sci Transl Med       Date:  2011-09-21       Impact factor: 17.956

2.  Development and morphogenesis of human wrist joint during embryonic and early fetal period.

Authors:  Fidel Hita-Contreras; Antonio Martínez-Amat; Raúl Ortiz; Octavio Caba; Pablo Alvarez; José C Prados; Rafael Lomas-Vega; Antonia Aránega; Indalecio Sánchez-Montesinos; Juan A Mérida-Velasco
Journal:  J Anat       Date:  2012-03-19       Impact factor: 2.610

3.  Epiphyseal abnormalities, trabecular bone loss and articular chondrocyte hypertrophy develop in the long bones of postnatal Ext1-deficient mice.

Authors:  Federica Sgariglia; Maria Elena Candela; Julianne Huegel; Olena Jacenko; Eiki Koyama; Yu Yamaguchi; Maurizio Pacifici; Motomi Enomoto-Iwamoto
Journal:  Bone       Date:  2013-08-17       Impact factor: 4.398

4.  Hamate and pisiform coalition: a case report and introduction to the carpal C-sign on lateral radiograph.

Authors:  Jonathan Cortese; Marc Soubeyrand; Leo Razakamanantsoa; Marie-France Bellin; Maud Creze
Journal:  Skeletal Radiol       Date:  2017-02-22       Impact factor: 2.199

5.  Investigating the mechanistic basis of biomechanical input controlling skeletal development: exploring the interplay with Wnt signalling at the joint.

Authors:  Rebecca A Rolfe; Claire A Shea; Pratik Narendra Pratap Singh; Amitabha Bandyopadhyay; Paula Murphy
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-09-24       Impact factor: 6.237

6.  TGF-β type II receptor/MCP-5 axis: at the crossroad between joint and growth plate development.

Authors:  Lara Longobardi; Tieshi Li; Timothy J Myers; Lynda O'Rear; Huseyin Ozkan; Ying Li; Clara Contaldo; Anna Spagnoli
Journal:  Dev Cell       Date:  2012-07-17       Impact factor: 12.270

7.  Cell origin, volume and arrangement are drivers of articular cartilage formation, morphogenesis and response to injury in mouse limbs.

Authors:  Rebekah S Decker; Hyo-Bin Um; Nathaniel A Dyment; Naiga Cottingham; Yu Usami; Motomi Enomoto-Iwamoto; Mark S Kronenberg; Peter Maye; David W Rowe; Eiki Koyama; Maurizio Pacifici
Journal:  Dev Biol       Date:  2017-04-21       Impact factor: 3.582

8.  Early induction of a prechondrogenic population allows efficient generation of stable chondrocytes from human induced pluripotent stem cells.

Authors:  Jieun Lee; Sarah E B Taylor; Piera Smeriglio; Janice Lai; William J Maloney; Fan Yang; Nidhi Bhutani
Journal:  FASEB J       Date:  2015-04-24       Impact factor: 5.191

9.  Molecular profiling of the developing mouse axial skeleton: a role for Tgfbr2 in the development of the intervertebral disc.

Authors:  Philip Sohn; Megan Cox; Dongquan Chen; Rosa Serra
Journal:  BMC Dev Biol       Date:  2010-03-09       Impact factor: 1.978

10.  Sonic hedgehog signaling directly targets Hyaluronic Acid Synthase 2, an essential regulator of phalangeal joint patterning.

Authors:  Jiang Liu; Qiang Li; Michael R Kuehn; Ying Litingtung; Steven A Vokes; Chin Chiang
Journal:  Dev Biol       Date:  2013-01-08       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.